| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 08/09/2001 | US20010012517 Anticancer agent |
| 08/09/2001 | US20010012515 Isolated polypeptide |
| 08/09/2001 | US20010012514 Neutralizing, removal antibodies |
| 08/09/2001 | DE19953517C1 Verwendung von Treosulfan zur Konditionierung von Patienten vor Knochemarktransplantation oder Blutstammzelltransplantation Use of treosulphan for conditioning of patients before Knochemarktransplantation or blood stem cell transplantation |
| 08/09/2001 | CA2399809A1 Combinatorial protein domains |
| 08/09/2001 | CA2399603A1 Low dose haptenized tumor cell and tumor cell extract immunotherapy |
| 08/09/2001 | CA2399080A1 Humanized anti-ccr2 antibodies and methods of use therefor |
| 08/09/2001 | CA2399032A1 Ligands for fpr class receptors that induce a host immune response to a pathogen or inhibit hiv infection |
| 08/09/2001 | CA2399026A1 Mucin-1 derived antigens and their use in immunotherapy |
| 08/09/2001 | CA2398998A1 Cd40-binding apc-activating molecules |
| 08/09/2001 | CA2398957A1 Human herpesvirus 6a and 6b transfer factors for the treatment of chronic fatigue syndrome and multiple sclerosis |
| 08/09/2001 | CA2398915A1 Hyperthermia and immunotherapy for leukemias, lymphomas, and solid tumors |
| 08/09/2001 | CA2398816A1 Human immunodeficiency virus vaccine |
| 08/09/2001 | CA2398255A1 Bcl-2-like polynucleotides, polypeptides, and antibodies |
| 08/09/2001 | CA2396774A1 Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon |
| 08/09/2001 | CA2369050A1 Methods for preventing or attenuating pathoangiogenic conditions |
| 08/08/2001 | EP1121938A2 Prevention of sudden infant death |
| 08/08/2001 | EP1121937A1 Vaccine preparations containing saponins |
| 08/08/2001 | EP1121598A1 Detection of pleiotrophin |
| 08/08/2001 | EP1121454A1 Extracellular novel rage binding protein (en-rage) and uses thereof |
| 08/08/2001 | EP1121439A2 Methods and compositions for inhibiting neoplastic cell growth |
| 08/08/2001 | EP1121435A1 Camel, an alternative translation product of the tumour antigen lage-1 |
| 08/08/2001 | EP1121430A1 Human isre-binding protein |
| 08/08/2001 | EP1121427A1 (mbp1) polypeptides capable of interacting with oncogenic mutants of the p53 protein |
| 08/08/2001 | EP1121420A2 Hepatitis a vaccines |
| 08/08/2001 | EP1121383A1 Methods for the production of antibodies to specific regions of cyclosporine and cyclosporine metabolites |
| 08/08/2001 | EP1121373A2 Immunostimulatory oligonucleotides with modified bases and methods of use thereof |
| 08/08/2001 | EP1121156A2 Polymer conjugates of interferon beta- 1a and their uses |
| 08/08/2001 | EP1121150A1 Delta 6 fatty acid desaturase |
| 08/08/2001 | EP1121149A1 Staphylococcal immunotherapeutics via donor selection and donor stimulation |
| 08/08/2001 | EP1121148A2 Immunostimulant emulsion |
| 08/08/2001 | EP1121147A1 Substantially non-toxic biologically active mucosal adjuvants in vertebrate subjects |
| 08/08/2001 | EP1121136A2 Methods of administering adenoviral vectors |
| 08/08/2001 | EP1121135A1 Compositions of beta-glucans and specific igiv |
| 08/08/2001 | EP0831779B1 Process for making liposome preparation |
| 08/08/2001 | EP0786004B1 Cloning, expression and characterisation of a novel form of phosphatidylinositol-3-kinase |
| 08/08/2001 | EP0726949B1 Opioid receptor: compositions and methods |
| 08/08/2001 | EP0669829B1 Enhancement of xenograft tolerance and porcine cytokines therefor |
| 08/08/2001 | CN1307638A Host-encoded protein expressed on Marek's disease (MDV)-infected cells and antibody thereto |
| 08/08/2001 | CN1307636A Endometriosis-associated gene |
| 08/08/2001 | CN1307590A Treating and diagnosing macrophage-mediated diseases using FC receptor ligands |
| 08/08/2001 | CN1307484A Antibodies against human CD40 |
| 08/08/2001 | CN1307483A Adjuvant and vaccine composition containing monophosphoryl lipid A |
| 08/08/2001 | CN1307138A Expression vector pBVIL1 and its construction method and use |
| 08/08/2001 | CN1307061A Praparation of anticaries bacteria IgY, and anticaries composition |
| 08/08/2001 | CN1307000A Vaccine for hoof-and-mouth disease and preparing method thereof |
| 08/08/2001 | CN1306861A Polysaccharide with certain immunological activity and its preparation |
| 08/08/2001 | CN1306860A Composition and preparation of human tumor antigen-mycobacterium heat shock protein tumor vaccine |
| 08/08/2001 | CN1306859A Preparation of antineoplastic immune vaccine |
| 08/08/2001 | CN1069217C Immune serum globulin for intravenous injection and preparing method thereof |
| 08/08/2001 | CN1069216C Process for production of attenuated varicella zoster virus vaccine |
| 08/07/2001 | US6271368 Nucleotide sequences coding moduator of cellular activities; for the use in the prevention of plant consumption; viricides |
| 08/07/2001 | US6271354 Microorganism fusion polypeptide; for use in treatment of viral diseases; viricides |
| 08/07/2001 | US6271353 Antibodies specific for human adseverin |
| 08/07/2001 | US6271204 Activation of pyruvate dehydrogenase phosphatase |
| 08/07/2001 | US6271200 Proteinic drug delivery system using aerosolized membrane-mimetic amphiphiles |
| 08/07/2001 | US6271198 Constrained helical peptides and methods of making same |
| 08/07/2001 | US6271017 Genes of Heliciobacter pylori necessary for the regulation and maturation of urease and their use |
| 08/07/2001 | US6271011 A recombinant dna molecule from pasteurella multocida; diagnosis and therapy for respiratory tract infections, veterinary medicine; vaccines for both animals and humans |
| 08/07/2001 | US6270999 A streptococcal polynucleotide encoding a polypeptide of the lysyl trna synthetase family; diagnosis and therapy of otitis media, conjunctivitis, pneumonia, meningitis, sinusitis; screening antibiotics |
| 08/07/2001 | US6270994 Smad6 and uses thereof |
| 08/07/2001 | US6270992 Histidine kinase of Staphylococcus aureus |
| 08/07/2001 | US6270991 A polynucleotide encoding an amino acid sequence; diagnosis and therapy for streptococcal infections; treatment of otitis media, conjunctivitis, pneumonia, meningitis, and sinusitis |
| 08/07/2001 | US6270975 Nucleotide sequences for use in the diagnosis of viral infection |
| 08/07/2001 | US6270960 Detecting microorganism in sample; incubate sample with preferential polypeptide and detect binding of preferential antibody |
| 08/07/2001 | US6270955 Pharmaceutical compositions and methods for producing antibodies to hepatitis b virus and kits and methods for detecting antibodies to hepatitis b virus |
| 08/07/2001 | US6270800 Aqueous solvent based encapsulation of a bovine herpes virus type-1 subunit vaccine |
| 08/07/2001 | US6270795 Method of making microencapsulated DNA for vaccination and gene therapy |
| 08/07/2001 | US6270778 Relates to genes encoding melanoma antigens recognized by t-cells and their corresponding proteins. |
| 08/07/2001 | US6270777 For protecting susceptible hosts against diseases caused by bacterial pathogens which secrete a zinc metalloprotease. |
| 08/07/2001 | US6270776 Recombinant mycobacterial vaccine |
| 08/07/2001 | US6270775 Streptococcal C5a peptidase vaccine |
| 08/07/2001 | US6270770 Production losses can be prevented by a live attenuated caa vaccine for mucosal administration. |
| 08/07/2001 | US6270769 Providing the antigen to which the ctl response is desired and providing an antigen formulation which consists of two or more of a stabilizing detergent, a micelle-forming agent, and an oil; antigen lacking an immunostimulating peptide component |
| 08/07/2001 | US6270766 Anti-TNF antibodies and methotrexate in the treatment of arthritis and crohn's disease |
| 08/07/2001 | US6270765 Therapeutic compounds comprised of anti-Fc receptor antibodies |
| 08/07/2001 | US6270758 Substantially non-toxic biologically active mucosal adjuvants in vertebrate subjects |
| 08/07/2001 | US6270747 Inhibiting hypersecretion of mucus in lungs and airways by the administration of an egf-r antagonist. |
| 08/07/2001 | CA2191101C Materials and methods for treatment of plaquing diseases |
| 08/07/2001 | CA2139217C Vaccine composition for eliciting an immune response against n-glycolylated gangliosides and its use for cancer treatment |
| 08/07/2001 | CA2025607C Hydrophilic derivatives, their application to diagnosis and to therapeutics, diagnostic or therapeutic kits and immunological reagents |
| 08/07/2001 | CA1341281C Immunotherapy of tumor with monoclonal antibody against the 17-1a antigen |
| 08/02/2001 | WO2001055430A1 17 human secreted proteins |
| 08/02/2001 | WO2001055398A1 Burkholderia toxins |
| 08/02/2001 | WO2001055393A2 Mhc class ii restricted t cell epitopes from the cancer antigen ny-eso-1 |
| 08/02/2001 | WO2001055391A2 84p2a9: a prostate and testis specific protein highly expressed in prostate cancer |
| 08/02/2001 | WO2001055389A1 Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof |
| 08/02/2001 | WO2001055386A1 Toll-like receptor |
| 08/02/2001 | WO2001055353A2 Recombinant attenuation of prrsv |
| 08/02/2001 | WO2001055330A2 Recombinant rhabdoviruses as live-viral vaccines for immunodeficiency viruses |
| 08/02/2001 | WO2001055217A1 Ultra high affinity neutralizing antibodies |
| 08/02/2001 | WO2001055182A1 PROTEINS COMPRISING CONSERVED REGIONS OF NEISSERIA MENINGITIDIS SURFACE ANTIGEN NhhA |
| 08/02/2001 | WO2001055181A2 Recombinant multivalent malarial vaccines against plasmodium vivax |
| 08/02/2001 | WO2001055178A2 Liv-1 related protein, polynucleotides encoding the same and use thereof for treatment of cancer |
| 08/02/2001 | WO2001055177A2 Methods to identify ctl epitopes of hiv |
| 08/02/2001 | WO2001055174A2 Universal procedure for refolding recombinant proteins |
| 08/02/2001 | WO2001055169A1 Transgenic plant-based vaccines |
| 08/02/2001 | WO2001054732A1 Antibodies against ctla4 (cd152), conjugates comprising same, and uses thereof |
| 08/02/2001 | WO2001054725A1 Remedies and preventives for dental diseases |
| 08/02/2001 | WO2001054723A1 Therapeutic method for reducing angiogenesis |